Markets › Pakistan › KAR › CPHL

Citi Pharma Ltd

KAR:CPHLHealth TechnologyPSX:ALLSHRPSX:KMI30

Rs 62.35+1.12%LiveIn session · ≈ AED 0.8274 · Market cap $51.79M · Next earnings Wed 2 Dec

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	11.8%	12.8%	13.2%	11.6%	12.1%	14.6%	+2.5 pts
Operating margin	6.8%	9.2%	9.3%	8.8%	8.9%	11.4%	+2.5 pts
Net margin	4.1%	6.1%	6.7%	5.3%	6.7%	6.8%	+0.1 pts
EBITDA margin	8.3%	10.4%	10.1%	9.5%	10.1%	12.7%	+2.7 pts
Return on equity	14.7%	8.1%	13.9%	12.2%	14.8%	8.2%	−6.6 pts
Return on assets	5.8%	5.4%	8.0%	6.6%	7.3%	4.8%	−2.4 pts
Return on capital employed	19.6%	11.5%	17.7%	19.7%	19.0%	13.5%	−5.5 pts
Debt / equity	0.5×	0.1×	0.2×	0.3×	0.3×	0.3×	+8.1%
Debt / assets	18.6%	9.9%	11.6%	15.5%	12.3%	16.0%	+3.6 pts
Interest coverage	5.4×	13.1×	14.1×	7.8×	3.7×	4.7×	+25.6%
Current ratio	1.1×	2.5×	1.9×	1.5×	1.4×	1.3×	−4.9%
Quick ratio	0.4×	2.0×	1.3×	0.9×	0.8×	0.8×	−2.9%
Cash ratio	0.1×	1.7×	0.0×	0.0×	0.0×	0.1×	+426.3%
Asset turnover	1.4×	0.9×	1.2×	1.2×	1.1×	0.7×	−34.2%
Inventory turnover	3.5×	6.5×	5.0×	4.2×	3.3×	2.9×	−14.5%
Receivables turnover	11.7×	12.9×	6.6×	6.2×	5.1×	4.0×	−21.2%
Dividend payout	0.0%	0.0%	47.7%	0.0%	68.5%	82.9%	+14.4 pts